Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) is anticipated to issue its Q3 2025 results before the market opens on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.50) per share and revenue of $4.4870 million for the quarter. Individuals may visit the the company’s upcoming Q3 2025 earningresults page for the […]

Stratasys (NASDAQ:SSYS – Get Free Report) will likely be announcing its Q3 2025 results before the market opens on Thursday, November 13th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $136.5980 million for the quarter. Stratasys has set its FY 2025 guidance at EPS.Individuals may visit the the company’s […]

Chemomab Therapeutics (NASDAQ:CMMB – Get Free Report) will likely be announcing its Q3 2025 results before the market opens on Thursday, November 13th. Analysts expect Chemomab Therapeutics to post earnings of ($0.20) per share for the quarter. Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call […]

Shimmick (NASDAQ:SHIM – Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Thursday, November 13th. Analysts expect Shimmick to post earnings of ($0.04) per share and revenue of $120.20 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest […]

Emeren Group (NYSE:SOL – Get Free Report) is expected to announce its Q3 2025 results before the market opens on Thursday, November 13th. Analysts expect the company to announce earnings of $0.03 per share for the quarter. Individuals can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled […]